
|Articles|July 27, 2021
Pharmacy Clinical Pearl of the Day: Iron Deficiency, Anemia in Heart Failure Patients
Author(s)Saro Arakelians, PharmD
Heart failure outcomes improve with optimal iron levels.
Advertisement
Clinical Pearl of the Day:
- Patients with heart failure patients must be evaluated and treated for Iron deficiency and anemia.
- Prevalence over 50% in ambulatory patients.
- Iron deficiency in heart failure is defined as: ferritin < 100 µg/L or ferritin of 100-299 µg/L with a transferrin saturation <20%.
Explanation:
Iron deficiency:
- Should be screened and treated for patients with heart failure.
- Heart failure outcomes improve as iron levels improve.
- Intravenous iron replacement is needed because oral iron replacement trials do not show benefits.
- Risk factors for iron deficiency include female sex, advanced heart failure, higher levels of NTpro BNP and C reactive protein.
Reference
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Implementing Enfortumab Vedotin-ejfv Plus Pembrolizumab: Navigating Safety Data and the Pharmacist’s Role
2
Daratumumab Boosts Depth and Durability of Response After ASCT, Offering Clear Guidance for Pharmacist Counseling
3
Improving Outcomes in Diffuse B-Cell Lymphoma Requires Multidisciplinary Evolution
4
American Cancer Society Updates Cervical Cancer Screening Guidelines to Include Self-Collection for HPV Testing
5

















































































































































































































